Description
SR9009, also known as Stenabolic, is a synthetic compound often mistaken for a SARM (Selective Androgen Receptor Modulator) but is actually a REV-ERB agonist. It was developed to study circadian rhythm regulation and has shown potential in improving metabolism, endurance, and fat loss.
Key Benefits (Based on Animal Studies & Limited Human Data)
Increased Endurance – Enhances mitochondrial function, improving stamina and workout performance.
Fat Loss – Boosts metabolism and fat oxidation without affecting muscle mass.
Improved Metabolism – Increases glucose and lipid metabolism, potentially beneficial for weight management.
Enhanced Recovery – Reduces inflammation and muscle damage after exercise.
Potential Cardiovascular Benefits – May lower LDL cholesterol and improve heart health markers.
How It Works
SR9009 activates REV-ERBα and REV-ERBβ, proteins that regulate the body’s internal clock (circadian rhythm), metabolism, and fat storage.
It influences genes involved in fat and glucose metabolism, making the body burn more calories even at rest.
Unlike SARMs, SR9009 does not affect testosterone levels and does not require post-cycle therapy (PCT).
Dosage & Cycle
Typical Dose: 10-30 mg per day, split into multiple doses (due to a short half-life of 2-4 hours).
Cycle Length: 6-8 weeks.
Stacking: Often combined with SARMs like Cardarine (GW501516) for endurance or Ostarine (MK-2866) for lean muscle retention.
Side Effects & Risks
Short Half-Life: Requires frequent dosing (every 2-4 hours) for sustained effects.
Liver Stress: Some research suggests potential liver toxicity at high doses.
Lack of Human Studies: Most data comes from animal research, making its long-term effects on humans unclear.
Possible Sleep Disruptions: As it affects circadian rhythms, some users report trouble sleeping.
Legality & Availability
Not FDA-Approved for human use.
Banned in Sports – Listed as a prohibited substance by WADA (World Anti-Doping Agency).
Sold as a Research Chemical.
